Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 7, 2021Clinical Microbiology and InfectionOpen Access

Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status

View Full Paper
Ask AI
Bookmark
Share

Authors

DEDavid W. EyreHealth Protection ScotlandSLSheila LumleyMedawar Building for Pathogen ResearchJWJia WeiHealth Protection Scotland

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Eyre et al. (2021) studied this question.

synapsesocial.com/papers/6a758552756843cacbb20dfdhttps://doi.org/10.1016/j.cmi.2021.05.041
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status2021 · 55 citations
  2. 2Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates2020 · 2,754 citations
  3. 3Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers2020 · 1,027 citations
  4. 4Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine2021 · 803 citations
  5. 5Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial2020 · 2,633 citations